Pricing Log in Create free account

Omeros Corporation (OMER) vs Silence Therapeutics PLC Sponsored ADR (SLN)

Omeros Corporation and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. Omeros Corporation and Silence Therapeutics PLC Sponsored ADR are of similar size ($1.2B and $1.2B). Silence Therapeutics PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.8×. Omeros Corporation grew revenue faster over the last twelve months: 36.3% against −97.0%. Omeros Corporation has the higher net margin (128.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Omeros Corporation leads on 11 and Silence Therapeutics PLC Sponsored ADR on 5.

Valuation

Metric OMER SLN Biotechnology median
P/E 9.84 n/m 10.60
P/S 12.48 1,110.83 9.40
P/B n/m 24.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 12.30 1,025.03 9.02
Earnings yield 10.16% (6.49%) (32.88%)
Free cash flow yield (5.66%) (4.54%) (23.13%)

Profitability

Metric OMER SLN Biotechnology median
Gross margin 37.57% 79.50% 68.51%
Operating margin (74.88%) 0.00% 0.00%
Net margin 128.36% 0.00% 0.00%
Free cash flow margin (70.69%) 0.00% 0.00%
Return on equity (89.15%) (90.41%) (51.96%)
Return on assets 51.22% (44.14%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OMER SLN Biotechnology median
Revenue growth (TTM) 36.32% (96.97%) 6.76%
EPS growth (last fiscal year) 98.15% (90.91%) 29.88%
Revenue growth, 5-year CAGR 40.44% (39.74%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OMER SLN Biotechnology median
Debt to equity (1.89) 0.00 0.00
Current ratio 1.95 7.42 4.97
Net debt to EBITDA (0.30) 0.94 1.01

Dividend

Metric OMER SLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OMER SLN Biotechnology median
Market cap 1.24b 1.23b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack